FDA Warning Letter — Chongqing Carelife Pharmaceutical Co., Ltd.
The FDA took a Warning Letter action against Chongqing Carelife Pharmaceutical Co., Ltd. on Feb 14, 2017 (Chongqing, China). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action details
- Facility
- Chongqing Carelife Pharmaceutical Co., Ltd.
- Date
- Feb 14, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Center
- CDER
- Location
- Chongqing (China)